Viewing Study NCT06094920


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:13 AM
Study NCT ID: NCT06094920
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-04-22
First Post: 2023-10-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Sponsor: University Medical Center Groningen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module